EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NT-proBNP Levels in Hemodialysis Patients: Unrelated to Interdialytic Weight Gain, Limited in Detecting Left Ventricular Systolic Dysfunction, but May Identify Atrial Fibrillation

Maria Divani, Katerina Katsanaki, Maria Tziastoudi, Panagiota Makri, Christina Poulianiti, Evangelos Lykotsetas, Andriani Balatsouka, Ioannis Stefanidis, Theodoros Eleftheriadis

Kidney and Dialysis · 09.06.2026 · 6 (2) · 42

DOI: 10.3390/kidneydial6020042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney and Dialysis, online erschienen am 09.06.2026. Verfasst von Maria Divani und 8 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

N-terminal pro-B-type natriuretic peptide (NT-proBNP) is released in response to increased cardiac wall stress and is used as a biomarker for volume overload and heart failure (HF). It is also elevated in atrial fibrillation (AF) and inflammation. However, in hemodialysis (HD) patients, its interpretation is complicated by reduced renal clearance, large fluid shifts between dialysis sessions, and chronic inflammation.

Methods

In 123 HD patients, we examined the relationship between NT-proBNP and interdialytic weight gain, HF with preserved ejection fraction (HFpEF), left ventricular systolic dysfunction (LVSD), and AF, as well as the impact of inflammation. Clinical characteristics, laboratory data, and echocardiography (within three months) were evaluated, while serum NT-proBNP and calprotectin levels were measured by ELISA.

Results

NT-proBNP showed no association with interdialytic weight gain and did not identify HFpEF. Inflammatory markers (C-reactive protein and calprotectin) correlated positively with NT-proBNP. Multivariable analysis demonstrated that LVSD, AF, and inflammation remained independent predictors of NT-proBNP levels. Although NT-proBNP levels were higher in LVSD, its diagnostic performance was poor (AUC 0.627). In contrast, NT-proBNP was significantly elevated in patients with AF and showed good diagnostic performance (AUC 0.801).

Conclusions

In HD patients, NT-proBNP is not correlated with interdialytic weight gain, performs poorly as a marker of LVSD, but may serve as a useful marker of AF.

Zitieren

APA

Divani, M., Katsanaki, K., Tziastoudi, M., Makri, P., Poulianiti, C., Lykotsetas, E., Balatsouka, A., Stefanidis, I., & Eleftheriadis, T. (2026). NT-proBNP Levels in Hemodialysis Patients: Unrelated to Interdialytic Weight Gain, Limited in Detecting Left Ventricular Systolic Dysfunction, but May Identify Atrial Fibrillation. Kidney and Dialysis, 6(2), 42. https://doi.org/10.3390/kidneydial6020042

Vancouver

Divani M, Katsanaki K, Tziastoudi M, Makri P, Poulianiti C, Lykotsetas E, et al. NT-proBNP Levels in Hemodialysis Patients: Unrelated to Interdialytic Weight Gain, Limited in Detecting Left Ventricular Systolic Dysfunction, but May Identify Atrial Fibrillation. Kidney and Dialysis. 2026;6(2):42. doi:10.3390/kidneydial6020042

BibTeX
@article{Divani2026,
  author = {Divani, Maria and Katsanaki, Katerina and Tziastoudi, Maria and Makri, Panagiota and Poulianiti, Christina and Lykotsetas, Evangelos and Balatsouka, Andriani and Stefanidis, Ioannis and Eleftheriadis, Theodoros},
  title = {NT-proBNP Levels in Hemodialysis Patients: Unrelated to Interdialytic Weight Gain, Limited in Detecting Left Ventricular Systolic Dysfunction, but May Identify Atrial Fibrillation},
  journal = {Kidney and Dialysis},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {42},
  doi = {10.3390/kidneydial6020042}
}
Kostenlos starten →